ライフサイエンスコーパス: bariatric

1 lective surgery utilization, particularly in bariatrics, are not well understood.

2 A total of 354,865 bariatric cases were captured in 2015 to 2016.

3 o which stents are used in the management of bariatric complications and rates of reoperation remain

4 However, the safety and efficacy of bariatric embolization are unknown.

5 rpose To evaluate the safety and efficacy of bariatric embolization in severely obese adults at up to

6 Background Bariatric embolization is a new endovascular procedure t

7 Conclusion Bariatric embolization is well tolerated in severely obe

8 Results Bariatric embolization was performed successfully for al

9 case series, a novel therapy, transcatheter bariatric embolotherapy (TBE) of the left gastric artery

10 ed the proof-of-principle that transcatheter bariatric embolotherapy of the left gastric artery is we

11 It is unclear what share of bariatric episode spending may be due to unnecessary var

12 atobiliary, colorectal, gynecology oncology, bariatric, general, and urological surgery were included

13 d cardiovascular outcome trial evidence, and bariatric/metabolic procedures.

14 strectomy has rapidly become the most common bariatric operation performed in the United States, but

15 in cost sharing was associated with 5 fewer bariatric operations per 100,000 insured lives; this ass

16 Only 1% of eligible persons undergo bariatric operations, and this underutilization is often

17 surgery for the treatment of obesity (termed bariatric or metabolic surgery) reduces all-cause mortal

18 Bariatric outcomes are needed for shared decision-making

19 l surgical outcomes in well-defined low-risk bariatric patients have not been established so far.

20 n a large claims-based, nationwide cohort of bariatric patients with diabetes, those undergoing RYGB

21 gher annual case volumes for both SG and any bariatric procedure (224.3 cases/yr vs 73.4 cases/yr, P

22 The use of gastric bypass as the preferred bariatric procedure for patients with obesity and type 2

23 no consensus exists regarding the choice of bariatric procedure for specific groups of patients.

24 ntered decision making when choosing between bariatric procedure options.

25 ong-term outcomes of this commonly performed bariatric procedure should be considered alongside its w

26 As a primary bariatric procedure, SG leads to excellent weight loss,

27 There are approximately 252 000 bariatric procedures (per 2018 numbers) performed each y

28 Although bariatric procedures are associated with substantial wei

29 The comparative efficacy of various bariatric procedures for the remission of type 2 diabete

30 Modern bariatric procedures have strong evidence of efficacy an

31 d studies are needed to assess the effect of bariatric procedures on cardiovascular disease, cancer,

32 ; however, there is increasing evidence that bariatric procedures should also be considered for patie

33 o compare the effects of the two most common bariatric procedures, gastric bypass and sleeve gastrect

34 mes, and specifically compared the different bariatric procedures.

35 sing a database that captures >92% of all US bariatric procedures.

36 This voluntary program will pay bariatric programs a bonus if 90-day spending after surg

37 se seems to enhance the beneficial effect of bariatric (Roux-en-Y gastric bypass [RYGB]) surgery on i

38 Practicing bariatric surgeons (n = 25) participating in a statewide

39 We interviewed n = 34 bariatric surgeons at the end of a 2-year surgical coach

40 ined between 2015 and 2016 and were rated by bariatric surgeons in a blinded fashion using a validate

41 e to veterans with severe obesity, including bariatric surgeons, primary care providers, registered d

42 ted by 2 fellowship-trained, board-certified bariatric surgeons.

43 s in assessments of the metabolic effects of bariatric surgeries and their relationships with clinica

44 Bariatric surgeries are integral to the management of ob

45 and LRYGB are the 2 most commonly performed bariatric surgeries for the treatment of obesity.

46 s the BAs pool and its metabolic response to bariatric surgeries is not known.

47 In fresh healthy tissue (from bariatric surgeries), no appreciable fluorescence is det

48 key mediators of the glycemic control after bariatric surgeries.

49 Odds ratios (ORs) were increased after bariatric surgery (all types combined) for perinatal mor

50 Babies born after bariatric surgery (all types combined) weighed over 200

51 Bariatric surgery (BS) is associated with reductions in

52 morbidly obese patients who underwent prior bariatric surgery (BS) with those of nonobese patients f

53 Metabolic and bariatric surgery (MBS) is a safe and effective treatmen

54 subjects with T2D before and 8-12 days after bariatric surgery (sleeve gastrectomy or sleeve gastrect

55 xpectancy among patients treated with either bariatric surgery (surgery group) or usual obesity care

56 ess than those born to mothers without prior bariatric surgery (weighted mean difference -242.42 g, 9

57 The 2015-2018 Metabolic and Bariatric Surgery Accreditation and Quality Improvement

58 Data from the Metabolic and Bariatric Surgery Accreditation and Quality Improvement

59 2017 were identified from the Metabolic and Bariatric Surgery Accreditation and Quality Improvement

60 s and 30-day outcomes from the Metabolic and Bariatric Surgery Accreditation and Quality Improvement

61 Bariatric surgery achieves remission of diabetes, but me

62 he aim of this study was to evaluate whether bariatric surgery alters the progression of CKD to kidne

63 -pocket cost sharing, and the utilization of bariatric surgery among commercially insured patients.

64 Given the many long-term benefits of bariatric surgery among patients with previous transplan

65 Therefore, we assessed the safety of bariatric surgery among previous-transplant patients usi

66 uential liver samples, collected the time of bariatric surgery and 1 and 5 years later, to assess the

67 uded in the analysis, with 269,818 receiving bariatric surgery and 1,270,086 control patients.

68 49 was genotyped in 1852 patients treated by bariatric surgery and 1803 controls given usual care in

69 uded 33 studies with 14,880 pregnancies post-bariatric surgery and 3,979,978 controls.

70 The study included 22,198 subjects who had bariatric surgery and 66,427 nonsurgical subjects matche

71 is between patients with NAFLD who underwent bariatric surgery and a well-matched group of nonsurgica

72 gate the association between pregnancy after bariatric surgery and adverse perinatal outcomes.

73 ial fibrillation and the association between bariatric surgery and atrial fibrillation ablation outco

74 udies have examined the relationship between bariatric surgery and cancer risk.

75 determined in 104 obese patients undergoing bariatric surgery and concomitant liver biopsy.

76 Unpaired studies have shown bariatric surgery and dietary interventions to different

77 mediate the metabolic changes observed after bariatric surgery and might be manipulated for treatment

78 Improving access to bariatric surgery and public health campaigns can improv

79 Data on the relationship between bariatric surgery and risk of birth defects are conflict

80 Rs) and 95% CIs for the associations between bariatric surgery and the risk of birth defects, using l

81 in 3-HIB followed by a marked decrease after bariatric surgery and weight loss.

82 Addressing low utilization of bariatric surgery and weight management services is a pr

83 Patients with NAFLD who undergo bariatric surgery are at a decreased risk for progressio

84 duced increases in insulin sensitivity after bariatric surgery are at least partially mediated by mus

85 evidence for both the benefits and risks of bariatric surgery are needed to better guide shared deci

86 the survival times of patients who have had bariatric surgery are similar to those of the general po

87 Although the data on eating behavior after bariatric surgery are substantial, data on "intuitive ea

88 tion to promote weight loss and referral for bariatric surgery as indicated for management of obesity

89 The patients underwent bariatric surgery at a single center in France and were

90 pective review of all patients who underwent bariatric surgery at our institution over the last 16 ye

91 than or equal to 35 kg/m2, and approved for bariatric surgery at the Johns Hopkins Center for Bariat

92 atched 1:2 with patients who did not undergo bariatric surgery based on age, sex, and comorbid condit

93 dy, 1845 deliveries were among women who had bariatric surgery before pregnancy (0.08%).

94 We identified women who had bariatric surgery before pregnancy, and included nonobes

95 spective cohort study of patients undergoing bariatric surgery between 2005 and 2012 with follow-up t

96 s in infants born to women who had Roux-en-Y bariatric surgery between 2007 and 2014.

97 h obesity and T2DM-Ins who underwent primary bariatric surgery between 2009 and 2017.

98 Among 38,153 patients who underwent bariatric surgery between 2012 and 2016, the share of sl

99 761 acute care hospitals providing inpatient bariatric surgery between January 1, 2011 and September

100 tudinally monitor liver fat before and after bariatric surgery by using quantitative chemical shift-e

101 , obesity and treatments for obesity such as bariatric surgery can influence absorption, excretion, p

102 on of care and standardizing some aspects of bariatric surgery care may improve access to evidence-ba

103 al and metabolic parameters, suggesting that bariatric surgery causes T2D remission at least partiall

104 The bariatric surgery cohort had a significantly lower occur

105 examine incident cancer up to 10 years after bariatric surgery compared to the matched nonsurgical pa

106 for patients who have undergone any form of bariatric surgery compared with an appropriate control g

107 ficantly lower among those who had undergone bariatric surgery compared with matched nonsurgical pati

108 pants to describe their experiences with the bariatric surgery delivery process in the VA system.

109 , and total Medicare spending for the 90-day bariatric surgery episode using multivariable regression

110 lp guide decisions about procedure choice in bariatric surgery for patients with GERD.

111 needed to determine the long-term effects of bariatric surgery for patients with nonalcoholic steatoh

112 r findings suggest that a strategy utilising bariatric surgery for patients with obesity and T2DM-Ins

113 The results suggest that broader access to bariatric surgery for people with obesity may reduce the

114 We studied patients undergoing bariatric surgery from 2012 to 2016.

115 can commercial claims database who underwent bariatric surgery from 2014 to 2017.

116 Patients with NAFLD who undergo bariatric surgery generally have improvements in liver h

117 The bariatric surgery group (N = 2007, per-protocol) underwe

118 Future bariatric surgery guidelines should include NAFLD as a c

119 ric surgery: poor care coordination, lack of bariatric surgery guidelines, limited primary care provi

120 Patients undergoing bariatric surgery had a 33% lower hazard of developing a

121 s who did not have surgery, patients who had bariatric surgery had decreased overall mortality from a

122 Compared to gastric bypass, other types of bariatric surgery had lower risk of suicide (HR = 0.44,

123 Mortality after bariatric surgery has been previously studied, but cohor

124 Bariatric surgery has been shown to improve comorbid con

125 Bariatric surgery has been shown to improve or resolve m

126 Bariatric surgery has been shown to reduce the severity

127 Bariatric surgery has evolved over the past 2 decades.

128 Bariatric surgery has proven to be the most effective tr

129 tries, we found that obese patients who have bariatric surgery have longer survival times than obese

130 Perioperative safety of bariatric surgery improved over the last quarter-century

131 ort study included patients having undergone bariatric surgery in 1982 to 2012 in any of the 5 Nordic

132 pective cohort study of adults who underwent bariatric surgery in 6 US cities between 2006 and 2009 i

133 spective cohort study of patients undergoing bariatric surgery in a statewide quality collaborative b

134 olution of NASH was observed at 1 year after bariatric surgery in biopsies from 84% of patients, with

135 Bariatric surgery in obese cirrhotic patients is not ass

136 alth guidelines recommended consideration of bariatric surgery in patients with a body mass index (ca

137 rs later, to assess the long-term effects of bariatric surgery in patients with NASH.

138 neuropeptide, increases in circulation after bariatric surgery in rodents and humans and inhibits foo

139 FGF19), a gut hormone, is rapidly induced by bariatric surgery in rodents and humans.

140 We conclude that bariatric surgery in subjects with T2D rapidly reduces c

141 high fasting insulin levels benefitted from bariatric surgery in terms of reduced incidence of MI.

142 tritional approach may be complementary with bariatric surgery in the postoperative phase, which shou

143 Registry (NBSR), a comprehensive database of bariatric surgery in the United Kingdom, were extracted

144 An estimated 1,903,273 patients underwent bariatric surgery in the United States between 1993 and

145 with obesity diagnosis who underwent primary bariatric surgery in the United States from 1993 to 2016

146 in perioperative outcomes and utilization of bariatric surgery in the United States from 1993 to 2016

147 However, the perioperative safety of bariatric surgery in this patient population is poorly u

148 However, the use of bariatric surgery in this population can help optimize t

149 Median wait times for bariatric surgery increased from 86 to 159 days during t

150 Bariatric surgery is a treatment option for obese patien

151 Bariatric surgery is an effective treatment for severe o

152 Bariatric surgery is an efficient method to induce weigh

153 Despite its proven safety and efficacy, bariatric surgery is an underutilized therapy for severe

154 Bariatric surgery is associated with a reduction in arrh

155 Bariatric surgery is associated with decreased risk of s

156 This pooled analysis suggests that bariatric surgery is associated with reduced long-term a

157 retrospective cohort study examined whether bariatric surgery is associated with reduced risk of bre

158 ment of stents for management of leaks after bariatric surgery is common throughout the United States

159 Bariatric surgery is effective among patients with previ

160 Though bariatric surgery is increasing among Medicare beneficia

161 Bariatric surgery is known to reduce the long-term relat

162 Although bariatric surgery is performed in high volumes worldwide

163 Although bariatric surgery is performed in high volumes worldwide

164 Smoking behavior in the context of bariatric surgery is poorly described.

165 Bariatric surgery is quite effective, but is reserved fo

166 Evidence is emerging that bariatric surgery is related to an increased risk of sui

167 Bariatric surgery is safe, and healthcare utilization be

168 Although bariatric surgery is the most effective treatment for ob

169 Bariatric surgery is the most effective treatment for we

170 Bariatric surgery is the most effective weight loss opti

171 Although bariatric surgery is well established as an effective tr

172 larify the specific mechanisms through which bariatric surgery lowers cancer risk.

173 Bariatric surgery may be a viable option for patients wi

174 In some cases, bariatric surgery may be indicated to achieve and mainta

175 This suggests that women who have undergone bariatric surgery may benefit from specific preconceptio

176 Bariatric surgery might reduce overall mortality from ob

177 RYGB met international guidelines for having bariatric surgery more often than those receiving SG (91

178 ew large studies have examined the impact of bariatric surgery on cardiovascular outcomes, and specif

179 However, the long-term effect of bariatric surgery on clinically relevant liver outcomes

180 study set out to characterize the impact of bariatric surgery on long-term risk of thromboembolic ev

181 m of this study is to evaluate the effect of bariatric surgery on long-term risk of VTEs in a large c

182 g insulin, modifies the preventive effect of bariatric surgery on MI incidence.

183 Midterm effects of bariatric surgery on patients with obesity and hypertens

184 of this study were to examine the impact of bariatric surgery on T2DM resolution in patients with ob

185 This study examines the impact of bariatric surgery on the risk of myocardial infarction,

186 ecific level, and to elucidate the effect of bariatric surgery on the salivary microbiome which has n

187 Female bariatric surgery patients (N = 17,998) were matched on

188 is of Medicare claims (2012-2017) for 30,105 bariatric surgery patients entitled due to disability or

189 Of 49,977 bariatric surgery patients, 98 (0.2%) committed suicide

190 Women who undergo bariatric surgery prior to pregnancy are less likely to

191 Additionally, the impact of different bariatric surgery procedures on cardiovascular outcomes

192 Bariatric surgery reduced cardiac DFA uptake from a medi

193 Bariatric surgery reduces obesity-related mortality.

194 ted IgA(+) B cell populations in mice, while bariatric surgery regimen alters the level of fecal secr

195 Using data from a statewide bariatric surgery registry, a total of 988 patients with

196 Bariatric surgery results in increased intestinal secret

197 Bariatric surgery results in weight loss and health impr

198 Bariatric surgery reverses the hepatic features of NAFLD

199 Bariatric surgery seems to improve kidney injury, especi

200 Bariatric surgery should be considered as a treatment st

201 pendently associated with weight outcomes of bariatric surgery throughout 7 years of follow-up.

202 Multivariate analysis found bariatric surgery to be associated with reduced risk of

203 al studies comparing perinatal outcomes post-bariatric surgery to pregnancies without prior bariatric

204 We also examined seasonal trends in bariatric surgery utilization stratified by average leve

205 w-onset or worsening GERD symptoms following bariatric surgery varies by procedure, but there is a la

206 tion model to evaluate cost-effectiveness of bariatric surgery versus BMT for patients over a 5-year

207 Bariatric surgery was analyzed in relation to all-cause

208 Having bariatric surgery was associated with 1.20 times the ris

209 site cohort of patients with severe obesity, bariatric surgery was associated with a lower risk of in

210 Bariatric surgery was associated with a reduced rate of

211 We found bariatric surgery was associated with a reduced risk of

212 In multivariable adjusted models, bariatric surgery was associated with a reduced risk of

213 Bariatric surgery was associated with a reduced risk of

214 that in patients with obesity and T2DM-Ins, bariatric surgery was associated with high rates of post

215 Among patients with obesity, bariatric surgery was associated with longer life expect

216 Bariatric surgery was associated with substantially lowe

217 Over 5 years, bariatric surgery was cost saving compared to BMT (total

218 The association with bariatric surgery was greater for heart (RR: 1.47; 95% C

219 Utilization of bariatric surgery was higher in plans with lower cost sh

220 Cox proportional hazards modeling found that bariatric surgery was independently associated with a de

221 Among premenopausal women, the effect of bariatric surgery was more pronounced among ER-negative

222 y of 51 consecutive individuals referred for bariatric surgery was performed (from November 2011 to N

223 Bariatric surgery was shown to be associated with reduce

224 excess risk for self-harm/suicide related to bariatric surgery was stronger in men (sub-HR = 3.31, 95

225 Bariatric surgery was strongly associated with reduced i

226 Obesity without having bariatric surgery was, in contrast, more weakly associat

227 tients with traditional contraindications to bariatric surgery were excluded.

228 Patients undergoing concomitant bariatric surgery were excluded.

229 f a multi-center prospective cohort study of bariatric surgery were followed annually >=7 years.

230 Patients who underwent bariatric surgery were identified and matched 1:2 with p

231 A total of 2942 NAFLD patients who underwent bariatric surgery were identified and matched with 5884

232 2016 and 60,791 patients undergoing primary bariatric surgery were identified.

233 riatric surgery to pregnancies without prior bariatric surgery were included.

234 13 679 patients who underwent bariatric surgery were matched to 13 679 nonsurgical pat

235 d, and potential adverse outcomes related to bariatric surgery were not specifically examined due to

236 tric surgery at the Johns Hopkins Center for Bariatric Surgery were recruited for participation.

237 , 2017, 1305 patients who were preparing for bariatric surgery were screened, of whom 319 consecutive

238 Data from 3 national registries for bariatric surgery were used.

239 We studied the association of bariatric surgery with birth defects in future pregnanci

240 thought to be a promising strategy to mimic bariatric surgery with its multifaceted beneficial effec

241 ulation studies to assess the association of bariatric surgery with long-term mortality and incidence

242 h obesity who were undergoing evaluation for bariatric surgery with preoperative very low calorie die

243 vention (intensive lifestyle modification or bariatric surgery).

244 HS (which is more likely to be obtained with bariatric surgery).Conclusions: Clinicians may use these

245 patients, including 60,445 who had undergone bariatric surgery, and 268,362 matched nonsurgical contr

246 6 patients on the database who had undergone bariatric surgery, and equal numbers of age, sex, and bo

247 e obesity who were referred for or underwent bariatric surgery, and providers who delivered care to v

248 ents with severe obesity who did not undergo bariatric surgery, and results were even stronger when t

249 enced anastomotic or staple line leaks after bariatric surgery, and then evaluated for use of an endo

250 The surgical subspecialties included bariatric surgery, breast oncologic surgery, orthopedic

251 imes than obese individuals who did not have bariatric surgery, but their mortality is higher than th

252 view of observational studies, we found that bariatric surgery, especially gastric bypass, prior to p

253 e seem to increase the risk of suicide after bariatric surgery, indicating a role for tailored preope

254 against the MetS is weight loss, induced by bariatric surgery, lifestyle changes based on calorie re

255 iders and referring provider knowledge about bariatric surgery, long travel distances, delayed referr

256 II obesity (body mass index >=35 kg/m(2)) is bariatric surgery, namely, Roux-en-Y gastric bypass (RYG

257 At 5 years after bariatric surgery, NASH was resolved, without worsening

258 However, bariatric surgery, particularly malabsorptive procedures

259 For obese CKD patients who qualify for bariatric surgery, sleeve gastrectomy is often preferred

260 ive analysis of Medicare patients undergoing bariatric surgery, the largest components of 90-day epis

261 ollow-up of patients with NASH who underwent bariatric surgery, we observed resolution of NASH in liv

262 samples, collected from patients undergoing bariatric surgery, were analyzed using the optimized REI

263 heal CT morphology before and 6 months after bariatric surgery, with functional and symptomatic corre

264 The Longitudinal Assessment of Bariatric Surgery-2 is a prospective cohort study.

265 novel mechanisms and therapeutic targets for bariatric surgery-induced osteoporosis.

266 and disease with a special focus on obesity, bariatric surgery-induced weight loss, and immune checkp

267 al skill had higher complication rates after bariatric surgery.

268 her subgrouped based on the types of primary bariatric surgery.

269 nd comorbidity index to 53,889 women with no bariatric surgery.

270 specimens of 141 patients were taken during bariatric surgery.

271 68.81 pg/mL, p < 0.001) were elevated after bariatric surgery.

272 ified into 2 groups, based on utilization of bariatric surgery.

273 reat anastomotic and staple line leaks after bariatric surgery.

274 om 35 adult patients with obesity undergoing bariatric surgery.

275 s without cirrhosis (controls) who underwent bariatric surgery.

276 uman metabolism and the endocrine impacts of bariatric surgery.

277 tween intuitive eating and weight loss after bariatric surgery.

278 s with EO (n = 149) referred for weight loss/bariatric surgery.

279 aithfully replicating another key benefit of bariatric surgery.

280 ween intuitive eating and BMI decrease after bariatric surgery.

281 vailable, results were subgrouped by type of bariatric surgery.

282 as a result of metabolic improvements after bariatric surgery.

283 experiencing longer wait times when pursuing bariatric surgery.

284 igher cost sharing have lower utilization of bariatric surgery.

285 etworks and targeted women who had undergone bariatric surgery.

286 ity may also benefit from pharmacotherapy or bariatric surgery.

287 Among 505,258 participants, 49,977 had bariatric surgery.

288 The outcome was utilization of bariatric surgery.

289 incident breast cancer up to 10 years after bariatric surgery.

290 in Medicare's bundled payment initiative for bariatric surgery.

291 ents with these conditions choose to undergo bariatric surgery.

292 ated by weight loss, such as that induced by bariatric surgery.

293 detection of NASH in individuals undergoing bariatric surgery.

294 st large-scale episodic bundling program for bariatric surgery.

295 t placement for postoperative leak following bariatric surgery.

296 (7) What is the optimal time for bariatric surgery: before, during, or after LT?

297 re mapped onto Andersen model as barriers to bariatric surgery: poor care coordination, lack of baria

298 ustained diabetes remission after metabolic (bariatric) surgery for the treatment of obesity.

299 13,582 bariatric surgical patients and 45,948 reference individ

300 Clinical data from the National Bariatric Surgical Registry (NBSR), a comprehensive data